Diaxonhit SA Stock Euronext Paris
Equities
ALEHT
FR0004054427
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- EUR | - |
Jun. 24 | Proteomics International Laboratories Taps French Distributor for Diabetic Kidney Disease Test | MT |
May. 08 | Eurobio Scientific: agreement with Myriad Genetics | CF |
Sales 2024 * | 138M 149M | Sales 2025 * | 148M 160M | Capitalization | 142M 153M |
---|---|---|---|---|---|
Net income 2024 * | 9M 9.74M | Net income 2025 * | 11M 11.91M | EV / Sales 2024 * | 0.95 x |
Net cash position 2024 * | 9.9M 10.72M | Net cash position 2025 * | 32.8M 35.51M | EV / Sales 2025 * | 0.73 x |
P/E ratio 2024 * |
14.8
x | P/E ratio 2025 * |
11.7
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 51.91% |
Managers | Title | Age | Since |
---|---|---|---|
Denis Fortier
CEO | Chief Executive Officer | - | 17-06-18 |
Director of Finance/CFO | 43 | 22-09-30 | |
Cathie Marsais
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Denis Fortier
CEO | Chief Executive Officer | - | 17-06-18 |
Director/Board Member | 68 | 09-11-03 | |
Director/Board Member | 67 | 17-06-14 |
1st Jan change | Capi. | |
---|---|---|
+17.09% | 45.34B | |
+42.10% | 40.42B | |
-9.70% | 37.92B | |
+33.28% | 31.75B | |
-8.98% | 27.71B | |
+13.37% | 26.52B | |
+44.11% | 13.96B | |
+32.33% | 12.44B | |
-7.26% | 11.26B |
- Stock Market
- Equities
- ALERS Stock
- ALEHT Stock